530119 — Natraj Proteins Cashflow Statement
0.000.00%
- IN₹153.59m
- IN₹270.03m
- IN₹1.94bn
- 62
- 93
- 31
- 70
Annual cashflow statement for Natraj Proteins, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 3.16 | 9.78 | 130 | 10.1 | -125 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 37.2 | 19 | 17.2 | 15.6 | 26.5 |
Other Non-Cash Items | |||||
Changes in Working Capital | -29.9 | 50 | -91.7 | -2 | 37.6 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 17.4 | 85.2 | 59 | 28 | -56 |
Capital Expenditures | -1.56 | -0.01 | -18.6 | -21.4 | -0.903 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 2.69 | -1.29 | -15.4 | -6.85 | 5.74 |
Other Investing Cash Flow | |||||
Cash from Investing Activities | 1.13 | -1.3 | -33.9 | -28.3 | 4.83 |
Financing Cash Flow Items | -36.1 | -18.1 | -10.7 | -17.6 | -29.5 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -36.3 | -105 | 20.7 | -24 | 34.4 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -17.8 | -21 | 45.8 | -24.3 | -16.8 |